Giulia C. Kennedy - Nov 11, 2022 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Nov 11, 2022
Transactions value $
-$30
Form type
4
Date filed
11/15/2022, 04:02 PM
Previous filing
Nov 8, 2022
Next filing
Dec 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Options Exercise $28.70 +2 +0% $14.34 68K Nov 11, 2022 Direct F1
transaction VCYT Common Stock Sale -$59 -2 0% $29.34 68K Nov 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Options Exercise $0 -2 -100% $0.00* 0 Nov 11, 2022 Common Stock 2 $14.34 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.
F2 The option is fully vested.